Cure8 regulatory brief
The work explores fundamental mechanisms by which inflammation may impair colonic epithelial identity and barrier integrity in ulcerative colitis — knowledge that could lead to new targets to improve mucosal healing.
Researchers studying IBD pathogenesis, epithelial biology, mucosal immunology, and clinicians interested in mechanisms of mucosal healing.
This is a funded basic research project using human colonic organoids derived from pluripotent stem cells that include tissue-resident macrophages to model inflammation in vitro.
The team will test how NF-kB–mediated inflammation represses SATB2 (Aim 1) and how SATB2 controls cell–cell junctions and inhibits fetal-like reversion to restore barrier integrity (Aim 2). Methods listed include CRISPR, ATAC-seq, ChIP-seq, and 3C-based chromatin assays to identify SATB2-dependent genes and chromatin architecture changes.
The project is preclinical and focused on molecular and cellular mechanisms rather than testing clinical treatments. Results could eventually inform therapies that boost epithelial barrier repair, but this record describes planned experiments rather than patient-facing findings.
This entry is a funded NIH project record describing planned laboratory research using organoid models and genomic/epigenomic assays. It is not a clinical trial or a report of therapeutic results; findings will require peer-reviewed publication and further validation before clinical application.
Review the original publication for the complete reporting, methods, and context.
Funding disclosed by the source: National Institute of Diabetes and Digestive and Kidney Diseases - R01DK141729 - $684,907
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
This project aims to improve prediction of autoimmune disease onset and immunotherapy-related autoimmunity by combining genetics and plasma proteins.
Genetic ancestry can influence IBD risk and disease course, and most prior studies focused on European populations.
The study links shared gene-expression patterns between IBD and ankylosing spondylitis and highlights STAT3 as a potential shared biomarker or therapeutic target, which could be relevant for understanding overlapping...
